EUVIMEDEUVIMED entdecken
Crossref

Licochalcone A from Ma-Xing-Shi-Gan decoction to prevent Asthma through the inhibition of ferroptosis CD4+ T Cell by GART/HSP90α signaling pathway

Yunyun Dai, Hefeng Yao, Zihan Yang, Junyang Wang, Leyi Yin, Wei Mao

International Immunopharmacology · 2026-06 · 179 · 116549

DOI: 10.1016/j.intimp.2026.116549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Yunyun Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University,…. Hauptthemen laut MEDLINE: Asthma, Chalcones, CD4-Positive T-Lymphocytes, Drugs, Chinese Herbal. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Chinese Medicine Research Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Asthma is a heterogeneous disease characterized by chronic airway inflammation and airway hyperresponsiveness. It represents the most common chronic respiratory condition in children and remains a highly prevalent disorder worldwide. PURPOSE We investigated that Licochalcone A (LA) from Ma-Xing-Shi-Gan decoction prevent Asthma and its mechanism. METHODS In this study, we employed both female nude mice and BALB/c mice. To identify the potential therapeutic targets ofLA, we integrated multiple target prediction databases, including HERB, STITCH, SwissTargetPrediction, CTD, and TCMSP, utilizing a systematic network pharmacology approach. RESULTS LA demonstrated protective effects against asthma in murine models; however, this efficacy was absent in nude mice, suggesting a T cell-dependent mechanism. Conversely, LA significantly attenuated both asthma symptoms and pulmonary fibrosis in BALB/c mice. Mechanistically, LA reduced oxidative stress in T cells within the asthma model and mitigated mitochondrial damage and ferroptosis in in vitro settings. Notably, the administration of a ferroptosis agonist abolished the protective effects of LA on T cells. Single-cell RNA sequencing identified Glycinamide ribonucleotide transformylase (GART) as a key candidate gene upregulated in asthmatic T cells. Further analysis revealed that LA suppresses the GART/Heat shock proteins 90 (Hsp90) signaling pathway. Overexpression of GART reversed the beneficial effects of LA. Molecular docking studies confirmed that LA directly binds to GART at residues Valine 57, Arginine 90, Glutamine 137, and Leucine 143. CONCLUSION In conclusion, LA, a bioactive component of the Ma-Xing-Shi-Gan decoction, exerts therapeutic effects against asthma by regulating T cell ferroptosis via suppression of the GART/HSP90α signaling pathway. Collectively, these findings suggest that LA represents a promising therapeutic candidate for alleviating T cell-mediated ferroptosis in asthma and other respiratory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaChalconesCD4-Positive T-LymphocytesDrugs, Chinese HerbalFerroptosisHSP90 Heat-Shock ProteinsAnti-Asthmatic AgentsAnimalsFemaleSignal TransductionMice, Inbred BALB CMiceHumansDisease Models, AnimalLung

Stichwörter der Autor:innen

AsthmaFerroptosisinGARTLicochalcone AT cells

Substanzen

ChalconesDrugs, Chinese Herballicochalcone AHSP90 Heat-Shock ProteinsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou 313000, China.
  • Department of Oncology, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical university, Huzhou 313000, China.
  • Department of Respiratory and Critical Care Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Department of Respiratory and Critical Care Medicine, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou 313000, China. Electronic address: drweimao@outlook.com.

Förderung

  • Chinese Medicine Research Program of Zhejiang Province

Zitieren

APA

Dai, Y., Yao, H., Yang, Z., Wang, J., Yin, L., & Mao, W. (2026). Licochalcone A from Ma-Xing-Shi-Gan decoction to prevent Asthma through the inhibition of ferroptosis CD4+ T Cell by GART/HSP90α signaling pathway. International Immunopharmacology, 179, 116549. https://doi.org/10.1016/j.intimp.2026.116549

Vancouver

Dai Y, Yao H, Yang Z, Wang J, Yin L, Mao W. Licochalcone A from Ma-Xing-Shi-Gan decoction to prevent Asthma through the inhibition of ferroptosis CD4+ T Cell by GART/HSP90α signaling pathway. International Immunopharmacology. 2026;179:116549. doi:10.1016/j.intimp.2026.116549

BibTeX
@article{Dai2026,
  author = {Dai, Yunyun and Yao, Hefeng and Yang, Zihan and Wang, Junyang and Yin, Leyi and Mao, Wei},
  title = {Licochalcone A from Ma-Xing-Shi-Gan decoction to prevent Asthma through the inhibition of ferroptosis CD4+ T Cell by GART/HSP90α signaling pathway},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {179},
  pages = {116549},
  doi = {10.1016/j.intimp.2026.116549}
}
Kostenlos starten →